Gara Jalqabaatti › Kanisa Harkaa › Virginia

Qorannoo klinikaalii Kanisa Harkaa Virginia keessatti

Qorannoo 27 Kanisa Harkaa f Virginia keessatti hirmaatuu jiru.

Magaalota Virginia keessatti

Takkalaa qorannoo (Ingiliffa)

The Vanguard Study: Testing a New Way to Screen for Cancer

Sentara Martha Jefferson Hospital, Charlottesville
Inova Schar Cancer Institute, Fairfax
Inova Fair Oaks Hospital, Fairfax
fi 5 dabalataa

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

VCU Massey Comprehensive Cancer Center, Richmond
VCU Community Memorial Health Center, South Hill
VCU Health Tappahannock Hospital, Tappahannock

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07283939

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07529808

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Chesapeake Regional Medical Center, Chesapeake
Augusta Health Center for Cancer and Blood Disorders, Fishersville
Bon Secours Memorial Regional Medical Center, Mechanicsville
fi 7 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

University of Virginia, Charlottesville
NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Site 04, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07814248

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Oncology and Hematology Associates of Southwest Virginia, Inc. - Salem, Salem

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07221149

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Virginia Cancer Specialists, PC, Arlington
Virginia Oncology Associates, Chesapeake
Virginia Cancer Specialists, PC, Fairfax
fi 7 dabalataa

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07392892

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Virginia Cancer Specialists, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Blacksburg
Research Site, Fairfax
Research Site, Fort Belvoir
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NEXT Oncology - Virginia Cancer Specialists, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06253871

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07227168

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Fairfax

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07115043

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07066657

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Virginia Oncology Associates, Norfolk
Blue Ridge Cancer Care, Roanoke

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06731478

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Fairfax

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07749586

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Oncology & Hematology Associates of Southwest Virginia, Roanoke

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT03526835

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT05208762

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Virginia Cancer Specialists, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Virginia Cancer Specialists, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT04389632

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT05005403

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Virginia Cancer Specialists, Fairfax

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06395519

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

NEXT Virginia, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07317505

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Dren Investigational Site, Fairfax

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ama-2026 · NCT06999187

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Charlottesville

Namoota walitti qabaa jiraQorannoo ilaalaa

Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

University of Virginia, Charlottesville

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT05107674

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.